Metabolic syndrome is a big risk factor for early dementia, and what you do makes a difference, study suggests
Get inspired by a weekly roundup on living well, made simple. Sign up for CNN's Life, But Better newsletter for information and tools designed to improve your well-being.
How you manage a cluster of health conditions known as metabolic syndrome could have a big impact on whether you develop dementia at a young age, according to a new study.
To be diagnosed with metabolic syndrome, a person must have three of the following conditions: a large waistline, high blood pressure, high blood sugar, high blood triglycerides, and low levels of high-density lipoprotein cholesterol, also known as HDL or 'good' cholesterol.
People who had metabolic syndrome, or a combination of those components, were 24% more likely to develop dementia at a young age, the data showed.
'The key takeaway (of the study) is that metabolic syndrome significantly increases the risk of developing young-onset dementia,' which is dementia before age 65, said principal study investigator Dr. Minwoo Lee, in an email. 'Our findings highlight the importance of managing metabolic health early to potentially prevent dementia and maintain brain health.'
The study analyzed data of nearly 2 million people from the Korean National Health Insurance Service who underwent health checkups. Researchers analyzed the markers of metabolic syndrome and who developed young-onset dementia between 2009 and the end of 2020, according to the study published Wednesday in the journal Neurology.
'Each component — such as elevated blood pressure, high blood sugar, obesity, abnormal cholesterol levels — is individually linked to higher dementia risk,' said Lee, assistant professor in the department of neurology at Hallym University Sacred Heart Hospital in South Korea.
The finding suggests an increased risk for much of the US population, as about 1 in 3 adults in the United States have metabolic syndrome, according to the National Heart, Lung, and Blood Institute.
'Dementia is among our most feared diseases, and developing dementia at an early age is even more worrisome,' said Dr. Richard Isaacson, a preventive neurologist and director of research at the Institute for Neurodegenerative Diseases in Boca Raton, Florida. He was not involved in the new study.
'People of all ages –– from the 20s, 30s, 40s, 50s and beyond –– should be empowered to make brain-healthy choices early on,' Isaacson said. 'I think this study gives us more evidence to suggest that these brain-healthy choices may lead to better brain outcomes over time.'
It is important to note that the study was observational, which means that researchers can't say that metabolic syndrome caused dementia, only that there was a correlation between the two, Isaacson said.
'I don't really think that vascular risk factors and metabolic syndrome causes Alzheimer's disease, but I think it can fast-forward someone towards it,' he said.
More research will need to be done to determine whether treating metabolic syndrome actually delays the onset of dementia or reduces the number of cases, Isaacson said. Researchers will also need to look into more populations to see if the results from South Korea can be broadly applied.
But the latest study does give hope that there are actions people can take to combat young-onset dementia, he said. 'Some people say young onset-dementia, you can't do anything about that –– it's preordained, but I don't agree with that. These lifestyle factors are nontrivial,' he added.
Lee believes people can influence their odds. 'My advice is to proactively manage metabolic health by maintaining a balanced diet, regular physical activity, and routine medical check-ups,' he said. 'Addressing metabolic syndrome early can substantially reduce the risk of dementia later in life.'
The conditions that make up metabolic syndrome may not seem immediately connected to dementia risk, but there are a few ways that vascular health can impact cognitive decline, Isaacson said.
Metabolic syndrome can lead to inflammation, and 'when someone has inflammation in the body and in the brain, it can fast-forward aging,' Isaacson said. 'And when you have inflammation in the brain, things don't work as well.'
Your blood vessels working efficiently is also important to cognitive health to keep enough oxygen flowing to the brain, he added.
And finally, he noted that metabolic syndrome may affect the brain's ability to metabolize energy, which may lead to cognitive impairment.
The different conditions that make up metabolic syndrome tend to happen together because they have similar causes and impact one another, he added.
'When a person is physically inactive and has an unhealthy diet … and someone is not sleeping and just kind of burning the candle at both ends … poor activity, low exercise: These are the medical or clinical manifestations of that sort of thing,' Isaacson said. 'That's why these risk factors often flock together — because they really are interrelated.'
Because both genetic and lifestyle factors contribute to dementia cases, some people can do everything their doctor suggests and still get dementia, Isaacson said. But making healthy lifestyle changes and addressing metabolic syndrome may still prevent or delay dementia in many people, he added.
Treatment for metabolic syndrome, which can also increase the risk of diabetes and cardiovascular conditions, starts with lifestyle changes, said Dr. Pam Taub, a preventive cardiologist and professor of medicine at the University of California San Diego. She was not involved in the research.
'In general, the lifestyle recommendations that we recommend are really having a balanced Mediterranean diet, a diet that is balanced in terms of proteins, carbohydrates, and fiber, and also limiting the amount of calorie intake,' she added.
Some of Taub's research into metabolic syndrome shows that time-restricted eating can help manage the conditions, she said.
Maintaining regular physical activity is key, though the amount and the proportion of strength, cardio and flexibility training may be specific to you and discussed with your doctor, she said. Getting enough sleep and handling stress are also essential in managing almost every chronic condition, she added.
'Of course, we can't control the stress that's thrown at us, but it's how we modulate our response that is important,' Taub said.
But lifestyle changes alone may not solve the problem completely, she said. Your doctor may recommend medications to help with blood pressure, blood sugar, insulin resistance, lipid lowering and weight management.
'It's really not one or the other,' Taub said. 'You have to synergize both lifestyle and pharmacology.'
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
RFK Jr. made some promises on vaccines to get confirmed. Is he breaking them?
The Trump era is rife with Republicans who abandon their principles in the name of toeing Donald Trump's line. But few have gambled with those principles recently like Louisiana Republican Sen. Bill Cassidy. The chairman of the Senate Health, Education, Labor and Pensions Committee in February played the pivotal role in confirming a longtime purveyor of vaccine misinformation, Robert F. Kennedy Jr., as Health and Human Services secretary. Cassidy did so despite often citing how 30 years of practicing medicine taught him how crucial vaccines are – and despite his very public reservations about Kennedy's views and motivations on the subject. He also did so at a time when vaccine skepticism has risen sharply on the right, meaning Cassidy's strongly held beliefs were already losing ground. At Kennedy's confirmation hearing, Cassidy recalled loading an 18-year-old woman who had hepatitis B onto an ambulance so she could get an emergency liver transplant. 'And as she took off, it was the worst day of my medical career, because I thought $50 of vaccines could have prevented this all,' Cassidy said. 'That was an inflection point in my career.' Cassidy, who faces reelection and likely a primary challenge in 2026, ultimately gave Kennedy a decisive vote, after obtaining what the senator cast as a series of vaccine-related concessions. But pretty much ever since then, Kennedy has tested the spirit of that agreement, if he hasn't violated it outright. Most recently, that took the form of Kennedy on Monday removing all 17 members of an expert panel of advisers that guides the federal government's vaccine recommendations. Many immediately cast this as contrary to what Kennedy promised Cassidy. It's not quite so simple, for reasons we'll get to. But plenty of other actions could fit into that category. For his part, Cassidy on Monday would not tell CNN whether he regrets his vote for Kennedy. Last month, the senator said Kennedy had 'lived up to' the agreement. But at other times, he has taken issue with Kennedy's actions. It's worth a review of what Cassidy said back then – and since. Cassidy laid out the conditions during a speech on the Senate floor. In those February remarks, Cassidy cited the same vaccine advisory panel Kennedy just cleared out. 'If confirmed, he will maintain the Centers for Disease Control and Prevention's Advisory Committee on Immunization Practices' recommendations without changes,' Cassidy said, according to video of his remarks. An old transcript of Cassidy's speech on his own website omitted the word 'recommendations,' leading Kennedy's critics on Monday to accuse him of breaking his word by changing the makeup of the committee itself. But Cassidy's comments pertained to the committee's recommendations. (CNN has reached out to Cassidy's office about the transcript.) Cassidy in an X post Monday expressed concern about what comes next. He cited a 'fear' that 'ACIP will be filled up with people who know nothing about vaccines except suspicion.' 'I've just spoken with Secretary Kennedy, and I'll continue to talk with him to ensure this is not the case,' he added. He declined to go further when pressed by CNN's Manu Raju. Cassidy also said in his February speech that Kennedy had 'committed that he would work within current vaccine approval and safety monitoring systems and not establish parallel systems.' But just in the past two weeks, Kennedy announced changes to the CDC's recommended vaccine schedules without ACIP's input. 'CDC will not remove statements on their website pointing out that vaccines do not cause autism,' Cassidy said in his speech. There is no evidence that the CDC has done this. But Kennedy has taken actions that seem geared toward his longstanding and debunked linking of vaccines to autism, which Cassidy took exception to at Kennedy's confirmation hearing. Most recently, this took the form of launching a 'massive testing and research effort' to find the causes of autism, which critics worry will be geared toward vaccines. And indeed, CNN previously reported HHS had asked the CDC to study vaccines and autism, despite strong evidence there's no link between the two. This is one area where Cassidy has expressed reservations. 'I'll point out that has been clearly laid to rest,' the senator said in April of the supposed link between vaccines and autism, according to The Advocate. 'The more resources we put towards that, we are not putting towards actually finding out what is the cause of autism.' Finally, Cassidy's floor speech suggested Kennedy had provided assurances that he wouldn't use his position to 'wrongfully' create suspicion about vaccines. 'I will watch carefully for any effort to wrongfully sow public fear about vaccines [through] confusing references of coincidence and anecdote,' Cassidy said. 'But my support is built on assurances that this will not have to be a concern …' There is no question Kennedy as HHS secretary has said many things that could undermine confidence in vaccines – often using misinformation. Amid a measles outbreak in Texas, Kennedy wasn't quick to explicitly recommend the measles-mumps-rubella vaccine, while floating unconventional treatments like vitamin A in ways that experts worried would discourage vaccinations. He also made a series of claims about the MMR vaccine that experts reject. These have included that it contains 'fetal debris' and that it 'was never safety tested.' He has also claimed that no childhood vaccine except the Covid-19 vaccine has been fully tested against placebos. But that's not true — something Cassidy pointed out in perhaps the most significant example of him calling out Kennedy. After Kennedy made the claim at a hearing last month, Cassidy returned to the hearing to correct him. 'The secretary made the statement that no vaccines except for Covid have been evaluated against placebo,' Cassidy said. 'For the record, that's not true. The rotavirus, measles and HPV vaccines have been, and some vaccines are tested against previous versions. So, just for the record to set that straight,' Cassidy said. It was the kind of claim that might lead one to wonder whether the guy you elevated to such a powerful position was actually living up to the agreement that got him there. Cassidy doesn't seem willing to go there yet. But all signs are Kennedy is going to continue making him second-guess his choices.
CNN
6 hours ago
- CNN
CDC vaccine adviser says panel's credibility ‘just disappeared overnight'
US Health and Human Services Secretary Robert F. Kennedy Jr. dismissed an expert panel of vaccine advisers, accusing them of being 'plagued with conflicts of interest.' CNN's Kate Bolduan speaks to one of those dismissed members about those claims and the effect this decision may have.
Medscape
11 hours ago
- Medscape
Forget the Tremor: These Symptoms Come First in Parkinson's
Patients with Parkinson's disease rarely present to the clinic with the textbook signs — forward stooped posture, slow and rigid movements, or shuffling gait. Instead, the earliest indicators are often vague and nonspecific, though they can later be recognized as early warning signs in retrospect. By the time the first clear symptoms appear, nearly 50% of dopaminergic neurons are irreversibly lost. The resulting dopamine deficiency disrupts the motor system, leading to hallmark symptoms such as tremor, rigidity, akinesia, and postural instability (TRAP). Diagnosis is clinical, supported by characteristic signs, and often confirmed with imaging (eg, dopamine transporter scan [DaT SCAN]). Onset is usually gradual and progressive, and symptoms may present asymmetrically. Although Parkinson's disease remains incurable, identifying these early signs before the onset of classic motor symptoms can enable timely monitoring and potential early intervention. The earlier the disease is detected, the better its progression may be slowed. Some symptoms may manifest years in advance. Below is an overview of early and prodromal Parkinson's symptoms. While most clinicians routinely ask about sleep or gastrointestinal function, the following list may help prompt more targeted follow-up when suspicion arises. Rapid Eye Movement (REM) Sleep Behavior Disorder (RBD) Sleep disturbances are often mentioned as early Parkinson's symptoms, but the specific disorder — REM sleep behavior disorder — is frequently overlooked. Unlike insomnia or sleep maintenance issues, RBD involves vivid dreaming accompanied by physical movements, such as shouting, punching, or kicking during sleep, often affecting the sleep partner. RBD occurs in about 0.5%-1% of the population, rising to 5% in those older than 60 years. Importantly, it is considered a prodromal condition for Parkinson's: 80% of those affected may go on to develop the disease within 15 years. Patients reporting these symptoms should be monitored regularly for neurologic changes. In clinical history-taking, ask specifically about vivid dreams, violent movements during sleep, or vocalizations. Though often dismissed as quirky or anecdotal, recurring incidents should raise red flags. Constipation Parkinson's doesn't begin with tremors or slowed movement. Nonmotor symptoms, especially gastrointestinal issues, often appear first. The disease affects the autonomic nervous system, including the enteric nervous system that regulates bowel motility. There is evidence that pathological changes — such as alpha-synuclein accumulation — begin in the gut and olfactory bulb before affecting the brain, aligning with the Braak hypothesis. These protein aggregates can cause constipation or olfactory dysfunction long before motor symptoms emerge. Studies suggest chronic constipation can precede a Parkinson's diagnosis by 10-20 years. Up to 75% of patients with Parkinson's experience it. While constipation alone is nonspecific, it gains significance when combined with other prodromal signs. Constipation should raise concern in these contexts: Persistent, unexplained symptoms. Co-occurrence with other early signs such as: Loss of smell (hyposmia). REM sleep behavior disorder. Depressed mood. Fatigue or lack of motivation. Family history of Parkinson's. Olfactory Dysfunction Loss of smell, either partial (hyposmia) or total (anosmia), is another early and often unnoticed sign. Patients may have difficulty detecting even strong odors like coffee, bananas, or pickles. In Parkinson's, misfolded alpha-synuclein protein aggregates disrupt brain regions, including those responsible for olfaction. These changes may impair neuron function and contribute to early sensory loss. Animal studies suggest alpha-synuclein may behave like a prion — spreading through neural pathways. Trials are ongoing to determine whether monoclonal antibodies such as prasinezumab could help degrade these protein aggregates. Micrographia As Parkinson's disrupts dopamine pathways, it impairs fine motor control. Writing — a highly complex motor task — often becomes affected. Reduced movement amplitude can lead to smaller, cramped handwriting known as micrographia. Micrographia is a typical, though not universal, early motor sign and may precede other motor symptoms. It often appears alongside other signs like a softer, monotone voice or reduced arm swing while walking — both early signs of extrapyramidal dysfunction. Classic Motor Signs: TRAP Parkinson's is commonly associated with: Tremor : A resting tremor, typically 4-8 Hz, which diminishes with movement (unlike intention tremor). : A resting tremor, typically 4-8 Hz, which diminishes with movement (unlike intention tremor). Rigidity : Muscle stiffness is often described as 'cogwheel rigidity' due to a ratcheting resistance during passive limb extension. : Muscle stiffness is often described as 'cogwheel rigidity' due to a ratcheting resistance during passive limb extension. Akinesia/bradykinesia : Slowness or poverty of movement, including 'freezing' episodes that require verbal cues to initiate or stop movement. : Slowness or poverty of movement, including 'freezing' episodes that require verbal cues to initiate or stop movement. Postural instability: Impaired balance and increased risk of falls, not due to cerebellar, visual, or vestibular dysfunction. Postural instability is now recognized as a cardinal sign in the TRAP framework. Damage to extrapyramidal reflexes means patients may be unable to catch themselves when off balance. Additional Early Signs Depression and anxiety : Often overlooked or misdiagnosed as primary psychiatric conditions. : Often overlooked or misdiagnosed as primary psychiatric conditions. Reduced facial expression (hypomimia) : 'Masked' appearance due to reduced facial muscle movement. : 'Masked' appearance due to reduced facial muscle movement. Diffuse pain : Especially in the shoulders, back, or arms, sometimes preceding motor signs. : Especially in the shoulders, back, or arms, sometimes preceding motor signs. Fatigue : Persistent lack of energy not relieved by rest. : Persistent lack of energy not relieved by rest. Reduced arm swing: Subtle early sign of movement asymmetry. When to Refer for Neurological Evaluation None of these symptoms alone confirm Parkinson's disease, as many are nonspecific or seen in other conditions. However, the presence of multiple early signs — especially the combination of REM sleep behavior disorder, olfactory loss, constipation, or family history — should prompt further evaluation. Referral should ideally be made to a neurologist specializing in movement disorders. A thorough neurologic exam, smell testing, sleep studies (polysomnography), and imaging (eg, DaT SCAN) may be warranted. Summary Table. Common Early and Prodromal Parkinson's Symptoms Symptom Description Frequency Lead Time Before Diagnosis Olfactory dysfunction (hyposmia) Reduced sense of smell; often the first sign, typically unnoticed Very common 5-15 years RBD Acting out dreams (eg, shouting, punching, or kicking) Common 10-15 years Depression, anxiety Mood disturbance, social withdrawal, loss of interest Common 5-10 years Constipation Reduced bowel motility; often chronic Common 10-20 years Pain (shoulders, back, or limbs) Diffuse musculoskeletal pain Common Can occur early Fatigue Chronic low energy not improved by sleep Moderate-common Years before diagnosis TRAP Classic cardinal signs (TRAP), often asymmetric at onset Very common Early symptom Micrographia Small, cramped handwriting Common Early symptom Hypomimia Mask-like facial expression Common Early symptom Reduced arm swing Asymmetry in arm movement while walking Common Early symptom RBD = rapid eye movement sleep behavior disorder; TRAP = tremor, rigidity, akinesia, and postural instability Identifying these signs early and recognizing meaningful combinations — not isolated symptoms — can help clinicians initiate earlier referral and intervention, potentially altering the disease trajectory.
